1
|
Menneteau T, Fabre B, Garrigues L, Stella A, Zivkovic D, Roux-Dalvai F, Mouton-Barbosa E, Beau M, Renoud ML, Amalric F, Sensébé L, Gonzalez-de-Peredo A, Ader I, Burlet-Schiltz O, Bousquet MP. Mass Spectrometry-based Absolute Quantification of 20S Proteasome Status for Controlled Ex-vivo Expansion of Human Adipose-derived Mesenchymal Stromal/Stem Cells. Mol Cell Proteomics 2019; 18:744-759. [PMID: 30700495 PMCID: PMC6442357 DOI: 10.1074/mcp.ra118.000958] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2018] [Revised: 01/21/2019] [Indexed: 01/18/2023] Open
Abstract
The proteasome controls a multitude of cellular processes through protein degradation and has been identified as a therapeutic target in oncology. However, our understanding of its function and the development of specific modulators are hampered by the lack of a straightforward method to determine the overall proteasome status in biological samples. Here, we present a method to determine the absolute quantity and stoichiometry of ubiquitous and tissue-specific human 20S proteasome subtypes based on a robust, absolute SILAC-based multiplexed LC-Selected Reaction Monitoring (SRM) quantitative mass spectrometry assay with high precision, accuracy, and sensitivity. The method was initially optimized and validated by comparison with a reference ELISA assay and by analyzing the dynamics of catalytic subunits in HeLa cells following IFNγ-treatment and in range of human tissues. It was then successfully applied to reveal IFNγ- and O2-dependent variations of proteasome status during primary culture of Adipose-derived-mesenchymal Stromal/Stem Cells (ADSCs). The results show the critical importance of controlling the culture conditions during cell expansion for future therapeutic use in humans. We hypothesize that a shift from the standard proteasome to the immunoproteasome could serve as a predictor of immunosuppressive and differentiation capacities of ADSCs and, consequently, that quality control should include proteasomal quantification in addition to examining other essential cell parameters. The method presented also provides a new powerful tool to conduct more individualized protocols in cancer or inflammatory diseases where selective inhibition of the immunoproteasome has been shown to reduce side effects.
Collapse
Affiliation(s)
- Thomas Menneteau
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France;; §STROMALab, Université de Toulouse, INSERM U1031, EFS, INP-ENVT, UPS, Toulouse, France
| | - Bertrand Fabre
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France
| | - Luc Garrigues
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France
| | - Alexandre Stella
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France
| | - Dusan Zivkovic
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France
| | - Florence Roux-Dalvai
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France
| | - Emmanuelle Mouton-Barbosa
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France
| | - Mathilde Beau
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France
| | - Marie-Laure Renoud
- §STROMALab, Université de Toulouse, INSERM U1031, EFS, INP-ENVT, UPS, Toulouse, France
| | - François Amalric
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France
| | - Luc Sensébé
- §STROMALab, Université de Toulouse, INSERM U1031, EFS, INP-ENVT, UPS, Toulouse, France
| | - Anne Gonzalez-de-Peredo
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France
| | - Isabelle Ader
- §STROMALab, Université de Toulouse, INSERM U1031, EFS, INP-ENVT, UPS, Toulouse, France
| | - Odile Burlet-Schiltz
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France;.
| | - Marie-Pierre Bousquet
- From the ‡Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS UMR 5089, UPS, Toulouse, France;.
| |
Collapse
|
3
|
Bertheuil N, Chaput B, Berger-Müller S, Ménard C, Mourcin F, Watier E, Grolleau JL, Garrido I, Tarte K, Sensébé L, Varin A. Liposuction Preserves the Morphological Integrity of the Microvascular Network: Flow Cytometry and Confocal Microscopy Evidence in a Controlled Study. Aesthet Surg J 2016; 36:609-18. [PMID: 26530477 DOI: 10.1093/asj/sjv209] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/14/2015] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Liposuction is a very popular technique in plastic surgery that allows for the taking adipose tissue (AT) on large surfaces with little risk of morbidity. Although liposuction was previously shown to preserve large perforator vessels, little is known about the effects of liposuction on the microvasculature network. OBJECTIVES The aim of this study was to analyze the effect of liposuction on the preservation of microvessels at tissue and cellular levels by flow cytometry and confocal microscopy following abdominoplasty procedure. METHODS Percentage of endothelial cells in AT from liposuction and en bloc AT was determined by multicolor flow cytometry. Moreover, vessel density and adipocyte content were analyzed in situ in 3 different types of AT (en bloc, from liposuction, and residual AT after liposuction) by confocal microscopy. RESULTS Flow cytometric analysis showed that en bloc AT contained 30.6% ± 12.9% and AT from liposuction 21.6% ± 9.9% of endothelial cells (CD31(pos)/CD45(neg)/CD235a(neg)/CD11b(neg)) (P = .009). Moreover, analysis of paired AT from the same patients (n = 5) confirmed a lower percentage of endothelial cells in AT from liposuction compared to en bloc AT (17.7% ± 4.5% vs 21.9% ± 3.3%, P = .031). Likewise, confocal microscopy showed that en bloc AT contained 8.2% ± 6.3%, AT from liposuction only 1.6% ± 1.0% (P < .0001), and AT after liposuction 8.9% ± 4.1% (P = .111) of CD31(pos) vessels. Conversely, adipocyte content was 39.5% ± 14.5% in the en bloc AT, 45% ± 18.4% in AT from liposuction (P = .390), and 18.8 ± 14.8% in AT after liposuction (P = .011). CONCLUSIONS For the first time, we demonstrate that liposuction preserves the microvascular network. Indeed, a low percentage of endothelial cells was found in AT from liposuction and we confirm the persistence of microvessels in the tissue after liposuction.
Collapse
Affiliation(s)
- Nicolas Bertheuil
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Benoit Chaput
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Sandra Berger-Müller
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Cédric Ménard
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Frédéric Mourcin
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Eric Watier
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Jean-Louis Grolleau
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Ignacio Garrido
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Karin Tarte
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Luc Sensébé
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| | - Audrey Varin
- Dr Bertheuil is a Staff Surgeon and Dr Waiter is a Professor, Department of Plastic, Reconstructive and Aesthetic Surgery, Hospital Sud, University of Rennes, Rennes, France. Dr Chaput is a Staff Surgeon, Department of Plastic, Reconstructive, and Aesthetic Surgery, Rangueil Hospital, Toulouse, France. Dr Berger-Müller has a Post-doctorate Position, Dr Sensébé is a Head Director of Team 2, and Dr Varin is a Staff Researcher, STROMALab Laboratory, Rangueil Hospital, Toulouse, France. Drs Ménard and Mourcin are Staff Researchers and Dr Tarte is a Professor and Head Director, SITI Laboratory, Rennes University Hospital, Rennes, France; and INSERM U917, University of Rennes, Rennes, France. Drs Grolleau and Garrido are Professors, Department of Plastic, Aesthetic, and Reconstructive Surgery, Toulouse University Hospital, Toulouse, France
| |
Collapse
|
12
|
Bouacida A, Rosset P, Trichet V, Guilloton F, Espagnolle N, Cordonier T, Heymann D, Layrolle P, Sensébé L, Deschaseaux F. Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells. PLoS One 2012; 7:e48648. [PMID: 23144918 PMCID: PMC3492496 DOI: 10.1371/journal.pone.0048648] [Citation(s) in RCA: 50] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2012] [Accepted: 09/27/2012] [Indexed: 01/18/2023] Open
Abstract
Mesenchymal stem cells (MSCs) and pericyte progenitors (PPs) are both perivascular cells with similar multipotential properties regardless of tissue of origin. We compared the phenotype and function of the 2 cell types derived from the same bone-marrow samples but expanded in their respective media - pericyte conditions (endothelial cell growth medium 2 [EGM-2]) for PPs and standard medium (mesenchymal stem cell medium [MSM]) for MSCs. After 3 weeks of culture, whatever the expansion medium, all cells showed similar characteristics (MSC markers and adipo-osteo-chondroblastic differentiation potential), although neuronal potential was greater in EGM-2- than MSM-cultured cells. As compared with MSM-cultured MSCs, EGM-2-cultured PPs showed higher expression of the pericyte-specific antigen 3G5 than α-smooth muscle actin. In addition, EGM-2-cultured PPs showed an immature phenotype, with upregulation of stemness OCT4 and SOX2 proteins and downregulation of markers of osteoblastic, chondroblastic, adipocytic and vascular smooth muscle lineages. Despite having less effective in vitro immunosuppression capacities than standard MSCs, EGM-2-cultured PPs had higher engraftment potentials when combined with biomaterials heterotopically-transplanted in Nude mice. Furthermore, these engrafted cells generated more collagen matrix and were preferentially perivascular or lined trabeculae as compared with MSM-cultured MSCs. In conclusion, EGM-2-cultured PPs are highly immature cells with increased plasticity and engraftment potential.
Collapse
Affiliation(s)
- Amina Bouacida
- Stromalab Unité Mixte de Recherche (UMR) Université Paul Sabatier/Centre National de la Recherche Scientifique (CNRS) 5273, U1031 Institut national de la santé et de la recherche médicale (Inserm), Etablissement Français du Sang-Pyrénées-Méditerranée, Toulouse, France
- EA3855, Université François Rabelais, Tours, France
| | - Philippe Rosset
- Inserm UMR957, Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Université de Nantes, Nantes, France
- Centre Hospitalier Universitaire Trousseau, Tours, France
| | - Valérie Trichet
- Inserm UMR957, Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Université de Nantes, Nantes, France
| | - Fabien Guilloton
- Stromalab Unité Mixte de Recherche (UMR) Université Paul Sabatier/Centre National de la Recherche Scientifique (CNRS) 5273, U1031 Institut national de la santé et de la recherche médicale (Inserm), Etablissement Français du Sang-Pyrénées-Méditerranée, Toulouse, France
| | - Nicolas Espagnolle
- Stromalab Unité Mixte de Recherche (UMR) Université Paul Sabatier/Centre National de la Recherche Scientifique (CNRS) 5273, U1031 Institut national de la santé et de la recherche médicale (Inserm), Etablissement Français du Sang-Pyrénées-Méditerranée, Toulouse, France
| | - Thomas Cordonier
- Inserm UMR957, Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Université de Nantes, Nantes, France
| | - Dominique Heymann
- Inserm UMR957, Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Université de Nantes, Nantes, France
| | - Pierre Layrolle
- Inserm UMR957, Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Université de Nantes, Nantes, France
| | - Luc Sensébé
- Stromalab Unité Mixte de Recherche (UMR) Université Paul Sabatier/Centre National de la Recherche Scientifique (CNRS) 5273, U1031 Institut national de la santé et de la recherche médicale (Inserm), Etablissement Français du Sang-Pyrénées-Méditerranée, Toulouse, France
| | - Frédéric Deschaseaux
- Stromalab Unité Mixte de Recherche (UMR) Université Paul Sabatier/Centre National de la Recherche Scientifique (CNRS) 5273, U1031 Institut national de la santé et de la recherche médicale (Inserm), Etablissement Français du Sang-Pyrénées-Méditerranée, Toulouse, France
- * E-mail:
| |
Collapse
|